Diagnostic and Therapeutic Uses of Radiation

For more than 50 years, the Center has been at the forefront of efforts to refine the use of ionizing radiation in diagnosis and lower the potential risk(s) of exposure. Significant new clinical treatment modalities, including the widespread use of high dose-rate fractionated brachytherapy for prostate cancer, were developed by scientists at the CRR.

Center faculty have made important contributions to our understanding of the individual health risks from repeated diagnostic CT exposure, the age-related risk of future cancers arising from prior diagnostic and therapeutic radiation exposures and the genetic determinants underlying our individual sensitivity to ionizing radiation exposure. These findings are likely to be important in the future development of personalized medicine and individualized applications of ionizing radiation in diagnosis and treatment.

CRR scientists have been at the forefront of efforts to advise health care providers and evaluate health risks arising from accidental overexposure during medical diagnosis and treatment.